5-Nitro-1H-imidazole-2-carboxylic acid, 95.0%, 5g

2-(3-Methoxyoxetan-3-yl)ethan-1-ol, 98%, 500mg

2-Bromo-4-n-butylaniline, 93%, 25g

(R)-N-((R)-Adamantan-1-yl(5-(diphenylphosphanyl)-9,9-dimethyl-9H-xanthen-4-yl)methyl)-2-methylpropane-2-sulfinamide, 98%, 250mg

Propylenglykolphenylether, min 99 %, zur Synthese, 5 l, kunststoffverpackung.

2,2,2-Trifluoroacetic acid compound with 2-(8-azabicyclo[3.2.1]Octan-3-yl)acetic acid (1:1), 98%, 5g

Ethyl 5-amino-1-phenyl-1H-pyrazole-4-carboxylate, 98.0%, 25g

1-[(4-chlorophenyl)methyl]-3-nitro-1H-pyrazole, 95.0%, 1g

4-Fluorophenylsulfur Pentafluoride>95.0%(GC)1g

Ethyl 2-oxohexanoate, 95.0%, 500g

(E)-N-(4-Methoxybenzylidene)aniline, 25g

2-ETHYL-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE, 95.0%, 500mg

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarbonitrile, 95.0%, 10g